221 related articles for article (PubMed ID: 24769262)
1. Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products.
Uchiyama N; Matsuda S; Kawamura M; Shimokawa Y; Kikura-Hanajiri R; Aritake K; Urade Y; Goda Y
Forensic Sci Int; 2014 Oct; 243():1-13. PubMed ID: 24769262
[TBL] [Abstract][Full Text] [Related]
2. Comments on "Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products".
Tsujikawa K; Iwata YT; Inoue M; Higashibayashi S; Inoue H
Forensic Sci Int; 2015 Jun; 251():e15-7. PubMed ID: 25911381
[No Abstract] [Full Text] [Related]
3. A synthetic cannabinoid FDU-NNEI, two 2
Uchiyama N; Shimokawa Y; Kikura-Hanajiri R; Demizu Y; Goda Y; Hakamatsuka T
Forensic Toxicol; 2015; 33(2):244-259. PubMed ID: 26257833
[TBL] [Abstract][Full Text] [Related]
4. Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry.
Shanks KG; Dahn T; Behonick G; Terrell A
J Anal Toxicol; 2012 Jul; 36(6):360-71. PubMed ID: 22586208
[TBL] [Abstract][Full Text] [Related]
5. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey.
Gurdal F; Asirdizer M; Aker RG; Korkut S; Gocer Y; Kucukibrahimoglu EE; Ince CH
J Forensic Leg Med; 2013 Aug; 20(6):667-72. PubMed ID: 23910858
[TBL] [Abstract][Full Text] [Related]
6. [Prevalence of new designer drugs and their legal status in Japan].
Kikura-Hanajiri R; Uchiyama N; Kawamura M; Ogata J; Goda Y
Yakugaku Zasshi; 2013; 133(1):31-40. PubMed ID: 23292017
[TBL] [Abstract][Full Text] [Related]
7. 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs?
Auwärter V; Dresen S; Weinmann W; Müller M; Pütz M; Ferreirós N
J Mass Spectrom; 2009 May; 44(5):832-7. PubMed ID: 19189348
[No Abstract] [Full Text] [Related]
8. Identification of a cannabinoid analog as a new type of designer drug in a herbal product.
Uchiyama N; Kikura-Hanajiri R; Kawahara N; Haishima Y; Goda Y
Chem Pharm Bull (Tokyo); 2009 Apr; 57(4):439-41. PubMed ID: 19336947
[TBL] [Abstract][Full Text] [Related]
9. [New psychotropic drugs - "legal highs"].
Scherbaum N; Schifano F; Siemann H
Fortschr Neurol Psychiatr; 2014 Sep; 82(9):532-43; quiz 543-4. PubMed ID: 25177905
[No Abstract] [Full Text] [Related]
10. [Analysis of newly distributed designer drugs detected in the products purchased in fiscal year 2008].
Uchiyama N; Miyazawa N; Kawamura M; Kikura-Hanajiri R; Goda Y
Yakugaku Zasshi; 2010 Feb; 130(2):263-70. PubMed ID: 20118651
[TBL] [Abstract][Full Text] [Related]
11. [Current situation and issues for analyzing illegal drug products].
Hasegawa T; Takahashi K; Saijo M; Fukiwake T; Motoki Y
Yakugaku Zasshi; 2013; 133(1):7-11. PubMed ID: 23292013
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.
Dresen S; Ferreirós N; Pütz M; Westphal F; Zimmermann R; Auwärter V
J Mass Spectrom; 2010 Oct; 45(10):1186-94. PubMed ID: 20857386
[TBL] [Abstract][Full Text] [Related]
13. [Beta-cathinone derivatives--a new generation of dangerous psychostimulant "designer drugs"].
Zawilska JB; Słomiak K; Wasiak M; Woźniak P; Massalski M; Krupa E; Wojcieszak JŁ
Przegl Lek; 2013; 70(6):386-91. PubMed ID: 24052975
[TBL] [Abstract][Full Text] [Related]
14. [Spice in France: mixed herbs containing synthetic cannabinoids].
Schlatter J; Chiadmi F; Chariot P
Ann Biol Clin (Paris); 2012; 70(4):413-22. PubMed ID: 22796613
[TBL] [Abstract][Full Text] [Related]
15. Forensic investigation of K2, Spice, and "bath salt" commercial preparations: a three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds.
Seely KA; Patton AL; Moran CL; Womack ML; Prather PL; Fantegrossi WE; Radominska-Pandya A; Endres GW; Channell KB; Smith NH; McCain KR; James LP; Moran JH
Forensic Sci Int; 2013 Dec; 233(1-3):416-22. PubMed ID: 24314548
[TBL] [Abstract][Full Text] [Related]
16. Phenazepam and cannabinomimetics sold as herbal highs in New Zealand.
Couch RA; Madhavaram H
Drug Test Anal; 2012 Jun; 4(6):409-14. PubMed ID: 22924168
[TBL] [Abstract][Full Text] [Related]
17. Instability of the hydrochloride salts of cathinone derivatives in air.
Tsujikawa K; Yamamuro T; Kuwayama K; Kanamori T; Iwata YT; Inoue H
Forensic Sci Int; 2015 Mar; 248():48-54. PubMed ID: 25594691
[TBL] [Abstract][Full Text] [Related]
18. Detection and quantification of new designer drugs in human blood: Part 2 - Designer cathinones.
Ammann D; McLaren JM; Gerostamoulos D; Beyer J
J Anal Toxicol; 2012 Jul; 36(6):381-9. PubMed ID: 22593565
[TBL] [Abstract][Full Text] [Related]
19. Direct analysis in real time mass spectrometry with collision-induced dissociation for structural analysis of synthetic cannabinoids.
Musah RA; Domin MA; Cody RB; Lesiak AD; Dane AJ; Shepard JR
Rapid Commun Mass Spectrom; 2012 Oct; 26(19):2335-42. PubMed ID: 22956326
[TBL] [Abstract][Full Text] [Related]
20. Changes in the prevalence of new psychoactive substances before and after the introduction of the generic scheduling of synthetic cannabinoids in Japan.
Kikura-Hanajiri R; Kawamura NU; Goda Y
Drug Test Anal; 2014; 6(7-8):832-9. PubMed ID: 24573957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
